Speaker: Gavin Giovannoni

0:26:57

Professor Gavin Giovannoni - Smoldering SPMS

0:25:02

UNDERSTANDING PROGRESSIVE FORMS OF MS FROM RWE DATA- GAVIN GIOVANNONI

0:52:13

MS Research Update - Professor Gavin Giovannoni

0:57:37

Prof Gavin Giovannoni: Managing MS remotely during the COVID-19 pandemic

1:01:39

Lymphopaenia – What is a safe lymphocyte count? | Prof Gavin Giovannoni, MS Academy #MSCovid19

0:58:51

Treating MS in 2014 - Professor Gavin Giovannoni

0:02:23

Strategies to target progression in MS

0:14:48

Stornoway MS Research Day: Looking to the Future by Gavin Giovannoni

0:03:10

The problem with defining types of MS

1:01:26

Live Webinar on MS-Self Management

0:02:22

COVID-19 outcomes in patients with relapsing MS receiving cladribine

0:03:57

CLASSIC-MS: 8-10 year follow-up of ORACLE trial shows long-term efficacy of cladribine for MS

0:51:33

Professor Gavin Giovanoni guest speaker at MS Ireland's 2018 National Conference

1:00:08

#MSCovid19 Question Time: 27/03/20 | G Giovannoni, D Martin, G Pepper, P Anderson, R Dorsey-Campbell

0:01:51

The benefits of treatments with minimal scientific basis in MS

0:15:02

A perspective on MS I hadn't heard before!

0:02:22

The challenges of screening and diagnosing multiple sclerosis

0:56:43

Multiple sclerosis - “A road less travelled with miles to go before I sleep

0:02:04

Future avenues of MS treatment

1:00:22

Anti-CD20 therapies and COVID-19 | MS Academy

0:25:05

MS Variance '19 – Chair presentations and discussions

0:58:32

How to prepare in the event of you getting Covid-19 | MS Academy #MSCovid19

0:09:14

The Kingdom of the Sick an interview with Rachel Horne - July 2020

0:01:50

Lessons to be learned from the laquinimod trial for MS